Edit
Accelerate Diagnostics
http://www.axdx.com/Last activity: 13.01.2022
Active - Reference to Accelerate Diagnostics
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
Location: United States, Arizona, Tucson
Employees: 201-500
Total raised: $578K
Founded date: 2004
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.06.2021 | Grant | $578K | CARB-X |
Mentions in press and media 2
| Date | Title | Description |
| 13.01.2022 | Accelerate Diagnostics : Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results - Form 8-K | Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results TUCSON, Ariz., January 13, 2022 -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the quarter ... |
| 12.01.2021 | Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results |